Clinical Trial

The Norwegian Cerebral Venous Thrombosis Study

Study acronym: NoCVT
Recruiting
View on ClinicalTrials.gov →
Summary
The NoCVT study will investigate CVT (2014-2023) in a large Norwegian population (\> 3 millions) using several approaches combining existing health registries, clinical databases and new prospectively collected clinical data to explore epidemiology, risk factors, diagnostics, treatment, and the long-term prognosis of CVT.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2021-08-23; most recent amendment 2025-02-03.
Trial Details
NCT Number NCT05021198
Lead Sponsor University Hospital, Akershus
Collaborators: Oslo University Hospital, Haukeland University Hospital, Drammen sykehus, Sorlandet Hospital HF, St. Olavs Hospital, Nordlandssykehuset HF, University Hospital of North Norway, University of Oslo, Rigshospitalet, Denmark, Hospital de Santa Maria, Portugal, Sykehuset Innlandet HF, Molde Hospital, Helse Stavanger HF, Sykehuset Telemark, Sykehuset i Vestfold HF
Conditions Cerebral Vein Thrombosis, Cerebral Venous Sinus Thrombosis
Enrollment 600 participants
Start Date 2014-01-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2025-02-05